Site-directed mutants of human myeloperoxidase A topological approach to the heme-binding site  by Jacquet, Alain et al.
May 19% Volume 302, number 2, 189-191 FEBS 11019 
Q 1992 Fcdcration of European Biochemical Socictics 00145793/92/%5.00 
Site-directed mutants of human myeloperoxidase 
A topological approach to the heme-binding site 
Alain Jacyuet, Virginie Deleersnyder, Lida Garcia-Quintana, Alex Bollen and Nicole Moguilevsky 
Received 4 March 1991 
Two sitc.dircctcd mutants of human promycloperoxidase, MPO(HisJ%Ala) and MPO(His”%Ala), have been expressed in Chinese I-,;trster 
ovary cells and purified. Overall purification yields and apparent molecular masses of the mutant proteins were similur to those oT the wild-type 
enzyme. Both mutant spccics wcrc analyzed spectroscopicttlly to check the prcscncc of the hcmic iron in the proteinsand were assayed for peroxidasic 
aclivity, The data show that substitution of Hi?‘: leads to the loss, or to an inappropriate configuration, of the hemc togcthcr with the loss of 
aciivity, suggesting thtit this residue could be the proximal His involved in the binding to the iron centers. On the other hand, substitution of Hi@ 
by alaninc had no cffcct on either of the studied paramctcrs. 
Recombinant myelopcroxidasc (human); Site-dircctcd mutagen&; Hcmc: Active site 
I. INTRODUCTION 
Myeloperoxidasc (MPO EC 1.11.1.7), a glycosylated 
hemoprotein present in polymorphonuclear leukocytes, 
catalyzes the oxidation of halides by hydrogen peroxide 
to generate potent oxidant species. The mature enzyme 
is a tetramer composed of two light (IO-15 kDa) and 
two heavy (57-60 kDa) chains [l]. Enzymatic activity 
depends on the iron atoms, one per heavy chain, in the 
hcme prosthetic group of MPO, The enzyme exhibits a 
characteristic absorption spectrum with a major red- 
shifted Soret band, at 428 nm, which is attributed to the 
unique iron-chlorin prosthetic group. Human recombi- 
nant MPO has been recently obtained from engineered 
Chinese hamster ovary cells. Although it is produced as 
a glycosylated single chain hemoprotein precursor of 
745 amino acid residues (84 kDa), recMP0 displays 
physico-chemical properties very similar to those of the 
mature natural enzyme [2,3]. The recombinant DNA 
methodology thus now offers the possibility to identify 
same amino acid residues involved in the catalytic 
mechanism and heme bindifig of MPO using site-di- 
rected mutagenesis of the corresponding cDNA, fol- 
lowed by the characterization ofexpressed mutant pro- 
,teins. The presence of a proximal histidine ligand to the 
heme iron in MPO has been indicated by a variety of 
spectral studies [4,5]. Some evidence has also been pre- 
sented to support a histidine residue on the distal side 
of the heme [6,7]. By analogy with the amino acid se- 
quence of thyroid peroxidase, it was proposed that 
Hisal of MPO could be the proximal ligand, binding to 
the iron centers and that HisSO’ of MPO could be the 
distal residue involved in the enzymatic degradation of 
hydrogen peroxide [8]. 
The present work consisted of creating site-directed 
MPO mutants where these two histidine were substi- 
tuted by alanine residues, and to characterize the mod- 
ified recombinant proteins in terms of optical absorp- 
tion spectrum and peroxidasic activity. 
2. MATERIALS AND METHODS 
Cur~~~~on&rtce ullress: A. Bollen. Applied Genetics. U.L.B.. rue de 
I’Industrie 24, B-1400 Nivcllcs, Belgium. 
Products used Tar recombinant DNA cxperimcnts. ccl1 culture and 
protein purification have been listed in a preccdingpdpcr [$I. Transfcc. 
tion of recombinant plasmids into CHO cells. selection and culture 
proccdurcs for transfcctcd cells, protein purification protocols. clcc- 
trophorctic analysis, Western blotting, ELISA and peroxidase activity 
assays for rcrMP0 have been detailed previously [Z]. The substitution 
mutants of recMP0. His’%Ala and His”‘%Ala, wcrc produced by 
subcloning the entire human MPO coding scqucnce, cxciscd as a 
Hirldlll-Slllrbl DNA fragment from plasmid pNIV2.703 [2], into 
Ml3mp18. which was then used as a tcnrplalc for oligonucleotidc. 
dirozud mulagcnesis using the method of Eckstcir. [9] (kit from Amcr- 
shun. UK). After mutagenesis. the appropriate mutated coding se. 
quenccs were sequcnccd. then rcleuscd by restriction digestion and the 
423.bp Apol-&nl fr@nICnl comprising the mulalions was substituted 
IO its wild-type counterpart in the complete MPD coding cassette 
carried by the cliprcssion vector pNIV2703. Final recombinant plas. 
mids, pNIV2707 and pNlV2708, were transTccted into CHO cells, 
G418-resistant colonies were sclccicd and suspended in six 175 cm’ 
Falcon flasks. Cell culture supxnatants (I liter) wcrc collcctcd for 
ciich ttansl’ccted cell line and processed to purify the mutant prolcin 
species [2]. Visible spectra were rL%ordcd on a Gary I5 spectrophoto. 
mcter,Thc presence or the hcmc in recombinant proteins was asses& 
by measuring the absorbance at 423 nm. Oligonucieotidrs wrrc’ syrl. 
thcsizcd on an Applied Biosystcms synthesizer model 380A via the 
solid-phase phosphoramiditc method [IO]. 
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Fig, 1. Schematic represel~t~tiott of he coding cassctli: for n~utai~t nlyclopero~idases. (A)coding cassette for \viId.type rccMP0 in pNIV~753. The 
Apul-K~~n1 l’ragmcnt is represented wilh nucleotide and amino-acid secpunccs surrounding His4” and His”‘z. (B) coding cussettc for His”‘“+Alu 
rccMP0 in pNlV2707. (C) codingcassetIe br His”‘+Al;1 rccMP0 in pNlV2708. In Bend C, the 21-mcr synthetic oligonucleotides Tar lntttitgenesis 
arc shown with the Ala codon and the newly crealed restriction site in bold. In each WC, full lines and -//- indicak the remainder of the 
~i~~dlll-~~f~~bl cassette. 
3. RESULTS 
Two site-directed mutations have been generated into 
the cDNA coding for human MPO. Both of them sub- 
stitute putativeIy importai~t histidi~~e r sidues, His”” 
and HisSo!, by alanine, a small non-polar amino acid. 
The mutations were created using the M I3mp18 mut- 
agenesis ystem and oligollucieotides carrying the ap- 
propriate mismatches (Fig. 1). AFter reconstruction of 
the mutated MPO coding modules, corresponding re- 
combinant plasmids, called pNlV2707 and pNIV2708, 
respectively, were used to transfect CHO cells in culture. 
Clones resistant o geneticin, having stably integrated 
the MPO cDNA. secreted the recombinant proteins in 
the medium. Two of them, His416-6 and H&502-8, pro- 
ducing I 182 and 1435 @ml/24 h, respectively, were 
expanded to obtain I liter of culture supernatant. which 
was used for Lhe purification of the n~uta~~t proteins, 
Overall purification yields for both mutant species were 
similar to that obtained for the wild-type recMP0 (50% 
final yields), In addition, the purified proteins migrated 
on SDS-PAGE as single-chain il~mulloreactive precur- 
sors having identical apparent masses as those observed 
for wild-type recMP0, 84 kDa and 94 kDa [2]. Visible 
spectra of the purified mutant proteins were compared 
to that of the wild-type spcciez. A.5 seen in Fig. 2. both 
wild-type and MPO(I-W6+Ala) mutant proteins pre- 
sented a major peak of absorbance at 428 nm (Sorer 
peak) and a minor one at 579 nm. In contrast, the 
mutant protein MPO(HisSo’-+Ala) did not show any 
visible spectrum at all (Fig, 2). 
The specific peroxidasic activity of mutant MP!Zfs was 
then determined using o-dianisidine as substrate [I 11. As 
seen in Fig. 3, MPO(Hi?“+Ala) displayed a similar 
dctivity as the wild-type enzyme, whereas*ihe other mu- 
190 
tant species, MPO(HisSu’+Ala), was totally inactive in 
the assay. The specific activity for the wild-type enzyme 
and MPO(His31h+Ala) was 0.1 I8 slnd 0.106 U/,ug, re- 
spectively, 
4, DISCUSSION 
The presence of distal and proximal histidines is a 
common feature, in many peroxidases, of the heme- 
binding site (for a recent review see ref. [ 12]), I3y analogy 
with MPO, Kimura et al. suggested that a similar situa- 
tion should prevail also in ~iulnan myeloperoxidase and 
that His”” could be the proximal histidine and Hiss” 
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Fig. 2. Visible absorption spectra oT recombinant MPOs. (---)* wild 
type rccMP0; (-- - - ), His”%Ala recMP0: (--s-*)% HitiD2+AIa 
recM PO. 
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Fig. 3, Peroxidasic activity of recombinant ntyclopcroxidascs using 
o-dianisidinc as substrate [IO]; the increase in Am,wits followed for one 
minute Idcnticul amounts of proteins (700 ng) were used in cuch 
assay. (-). wild type recMPG; (- - - -). His”‘‘-tAlu rccMP0; (-,-.). 
His”‘%Ala ret MPO. 
or His594, the distal histidine [S]. In this work, we con- 
structed and characterized site-directed mutants of 
human MPO which carry alanine residues instead of 
histidine at two of these positions. The results show that 
His”’ substituted by alanine led to the loss or inappro- 
priate configuration of the heme together with the loss 
of peroxidasic activity. We suggest hat the His?“’ rcsi- 
due constitutes the proximal histidine, involved in the 
binding to the iron centers, and not the distal His, as 
suggested before [8]. On the contrary, mutation of His”” 
had no effect on these parameters, indicating that this 
His residue does not correspond to the proximal histid- 
ine. 
The crystal structure of human MPO has currently 
been elucidated [12]; it will thus be interesting to con- 
front our conclusions to the crystallographic data. 
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